Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that it will be displaying several key scientific poster presentations at the American Academy of Dermatology (AAD) 64th Annual Meeting being held in San Francisco March 3-7, 2006.
